Paper published in a journal (Scientific congresses and symposiums)
Sofosbuvir + simeprevir +/-ribavirin treatment is efficient in genotype 4 chronic hepatitis C patients: results of a large international cohort.
Moreno, C; Derbala, M; Nguyen-Khac, E et al.
2016In Hepatology, 64 (1), p. 1990
Peer Reviewed verified by ORBi
 

Files


Full Text
AASLD 2016 gen 4 001.jpg
Publisher postprint (726.61 kB)
Download

All documents in ORBi are protected by a user license.

Send to



Details



Disciplines :
Gastroenterology & hepatology
Author, co-author :
Moreno, C
Derbala, M
Nguyen-Khac, E
Babatin, M
Rosa, I
Alzaabi, M
Hanslik, B
Mangia, A
Asselah, T
Buggisch, P
Mauss, S
Sersté, T
DELWAIDE, Jean ;  Centre Hospitalier Universitaire de Liège - CHU > Service de gastroentérologie, hépatologie, onco. digestive
Alkaabi, S
Pariente, A
Remy, A
Alghamdi, A
Cadranel, JF
Mohiuddin, S
Degré, D
More authors (10 more) Less
Language :
English
Title :
Sofosbuvir + simeprevir +/-ribavirin treatment is efficient in genotype 4 chronic hepatitis C patients: results of a large international cohort.
Publication date :
2016
Event name :
The Liver Meeting AASLD
Event place :
Boston, United States
Event date :
11-15 Novembre 2016
Audience :
International
Journal title :
Hepatology
ISSN :
0270-9139
eISSN :
1527-3350
Publisher :
Wiley, Hoboken, United States - New Jersey
Volume :
64
Issue :
1
Pages :
A1990
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 17 November 2016

Statistics


Number of views
46 (3 by ULiège)
Number of downloads
13 (0 by ULiège)

Bibliography


Similar publications



Contact ORBi